Published online November 1, 2004
PEDIATRICS Vol. 114 No. 5 November 2004, pp. 1333-1335 (doi:10.1542/peds.2004-0638)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenfeld, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenfeld, R. M.
Related Collections
Right arrow Infectious Disease & Immunity

COMMENTARY

Otitis, Antibiotics, and the Greater Good

Richard M. Rosenfeld, MD, MPH

Department of Otolaryngology, State University of New York Downstate Medical Center and the Long Island College Hospital, Brooklyn, NY 11201

Abbreviations: AOM, acute otitis media

The first 20% of the full text of this article appears below.

A major paradigm shift lies at the core of the new clinical practice guideline for acute otitis media (AOM),1 ie, the option of allowing selected children to fight an ear infection on their own before the initiation of antibiotic treatment. These children initially receive analgesics, with antibiotics being reserved for those whose conditions worsen or fail to improve within 48 to 72 hours. Although new to many US physicians, the observation option for AOM is an official policy in the Netherlands, Sweden, and now New York State.2 By offering the observation option, the new guideline changes the central AOM management decision from which antibiotic should be given3 to whether an antibiotic should be given at all.4

The paradigm shift is needed because 5.2 million AOM episodes each year5 are treated with antibiotics in the United States, although most would resolve spontaneously. Stated simply, this volume of antibiotic use for largely self-limiting infections does not serve the greater good. Antibiotics are therapeutic agents that affect society, not just individuals.6 Each course of therapy creates selective pressure for resistant bacteria in the child's nasopharynx, which spread readily among families, schools, and child care centers. These organisms, and those they create with resistance genes in transferrable plasmids, may cause fatal infections among healthy or immunocompromised individuals.7 The number of resistant bacterial pathogens throughout the world continues . . . [Full Text of this Article]

Address correspondence to Richard M. Rosenfeld, MD, MPH, Department of Otolaryngology, State University of New York Downstate Medical Center and the Long Island College Hospital, 339 Hicks St, Brooklyn, NY 11201. E-mail: richrosenfeld@msn.com




This article has been cited by other articles:


Home page
 PediatricsHome page
E. R. Wald
To Treat or Not to Treat
Pediatrics, April 1, 2005; 115(4): 1087 - 1089.
[Full Text] [PDF]